JMP Securities analyst Reni Benjamin maintains Kura Oncology (NASDAQ:KURA) with a Market Outperform and raises the price target from $22 to $32.
JMP Securities Maintains Market Outperform on Kura Oncology, Raises Price Target to $32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.